WHO ICTRP trial
Esmolol followed by metoprolol in the treatment of acute myocardial infarction
ChiCTR2000038206 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000038206 |
|---|---|
| Public title | Esmolol followed by metoprolol in the treatment of acute myocardial infarction |
| Scientific title | Esmolol followed by metoprolol in the treatment of acute myocardial infarction |
| Primary sponsor | Pingdingshan First People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Acute myocardial infarction |
| Interventions | experimental group:Sequential intravenous injection of esmolol immediately after treatment with metoprolol tablets;control group:metoprolol tablets |
| Registration date | Sep 13, 2020 |
| Target size | experimental group:50;control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: